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x l Introduction
In recent years there has been an increased possi-
bility to investigate the fünction of the feto-
placental unit with new radioimmunological
methods for several hormones, both steroids and
proteins, in urine, maternal plasma and in the
amniotic fluid.
In the laboratories of the Obstetric and Gyneco-
logical Clinic of the University of Genoa we have
monitored third trimester of pregnancy by
immunoassay of total Estripl (E3), Estetrol (E4),
Human Placental Lactogen (HPL) and Pregnancy
specific betai glycoprotein (SPj) in maternal
plasma and of E3 and E4 in amniotic fluid.
We have already discussed in earlier publications
why we prefer to measure plasma E3 rather
urinary, and total plasma E3 rather than free
[5, 6] and why we feil that the minimum for valid
monitoring is the evaluation of HPL plus E3 [5].
We have determinated our laboratory's mean
normal values and the Standard deviations of the
means for E3 and HPL and we have found that our
assay procedures and values are similar to those
reported in the literature for third trimester of
pregnancy [5]. We have used äs Standard values
for S?i those of the normal ränge published by
TOWLER et al. [25], while we have used those of
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TULCHINSKY et al. [29] for normal reference
values for E4 during pregnancy.
At the moment we are still accumulating assay
values for SPi and E4 for each week of pregnancy
in the Ligurian women who come to our Institute.
Our previous data [6] appear to have ruled out the
occurrence of any circadian rhythm of E3. Al-
though we have only preliminary data about the
concentrations of E3 and E4 in amniotic fluid [4],
our results with SPi assay s during normal preg-
nancies [7] have confirmed its usefulness äs a valid
test for placental fünction, especially in pregnancy
disorders and in pregnancies with retarded intraut-
erine growth.
In this paper we wish to report on the circadian
and day to day variations of all four hormone
levels (E3, E4, HPL and SP^ in plasma.
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2 Materials and methods
Seven volunteer patients were used for the study
of the circadian rhythm. Blood was taken at 8 and
12 a.m., 4, 8, 12 p.m. and again at 8 a.m. of the
next day.
Eight patients took part in the study of the day to
day variations. Fasting blood was taken every day
for 5 days, at 8 a.m. The blood samples were
immediatly centrifugated and the plasmas stored
at —20 fC until analysis. All assays were per-
formed on triplicate aliquots.
All the patients were in the third trimester of
normal pregnancy between the 26th week (one
case) and the 40th week after last menstruation.
All the patients were clinically normal (increase in
weight, blood pressure, uterine growth) had no
albuminuria and normal blood glucose levels.
They delivered spontaneously and without compli-
cations, all giving birth to live babies in good con-
dition, with normal weights for their gestational
ages, which had been evaluated in utero from the
fetal biparietal and transthoracic diameters in bi-
dimensional ultrasuonograms (B-scans) and were
evaluated at birth äs being between the lOth and
the 90th percentiles [20].
Total E3 was assayed with the radioimmunoassay
kits obtained from the Radiochemical Center
AMERSHAM (England).
A HEWLETT-PACKVRD gamma-counter, model
1511, was used for counting.
The interassay Variation was 12% and the intra-
assay Variation was less than 9%.
Unconjugated E4 was assayed using the method of
OLIVIERI and MANNA [19] using radioimmuno-
assay kits from BIODATA, Milan (Italy).
A BECKMAN LS 100 beta eounter was used for
counting.
The interassay Variation was 14% and the intra-
assay Variation was 8.8%.
HPL was assayed by the method of GENAZZANI
et al. [11] with radioimmunoassay kits obtained
from C. L S. SORIN, Saluggia, Italy.
The interassay Variation was 8% an4 the intra-
assay Variation was 5 %.
SPX was measured by BQHN's simple radial im-
munodiffusion method [2] using M-Partigen beta!-
SP1 glycoprotein plates obtained from BEHRING-
WERKE AG (Marburg, West Germany).
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The diametra of precipitate rings were measured
with a suitable device and concentrations read off
a linear plot of diameter vs. concentration ob-
tained with the Standard.
3 Results
The concentrations of all the hormones in the
plasma feil within the normal ranges.
The day to day variations for E3 and E4 are
shown in Fig. l and for HPL and SP^ in Fig. 2.
Fig. 3 and 4 show the variations within a single
day of the four hormones.
4 Discussion
Statistical analysis of our data showed that none
of the parameters demonstrate any circadian
rhythm, which confirms previous reports about E3
[6, 10, 16, 17], E4 [18, 29] and HPL [24].
There were striking variations during the day in
the steroids hormone levels, especially those of E4,
but much less so for the protein hormones, especi-
ally SP^
There were considerable differences in steroid hor-
mone levels between different patients at the same
stage of pregnancy and in the individual subjects at
the same time of day over the five days, äs well äs
a very considerable Standard deviation.
These differences were at least in part due to the
large interassay coefficient of Variation.
The differences and the Standard deviations were
much less marked for the protein hormones.
The day to day differences were also more marked
for the steroids (especially E4) than for the pro-
tein hormones.
The least variable of all was SP1.
5 Conclusions
There is no circadian rhythm of estriol, estetrol,
HPL and S?i. The within a day and day to day
variations are much greater for the steroid hor-
mones than for the protein ones. They are greater
for E4 than for E3 and for HPL than for S?!.
The Standard deviations were great for the steroids
(especially for E4) and much less for the proteins
(especially SPi).
This implies that it is necessary to have serial
assays of the steroids to have any confidence in
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the levels while good monitoring could be guaran-
teed with assays for HPL and SPi.
The evaluation of plasma concentrations of HPL
and SPi yields similar Information about placental
function.
SPX shows less Variation in the immunoassay than
does HPL, but its half-Hfe is 34 hours [3,23],
against a 20 minute half-life for HPL [24]. This
means that even though a single assay may give
more accurate picture of placental function [26],
if HPL samples taken closer together are assayed,
one can have a more up-to-the-minute indication
of the development of a pathological condition in
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the placenta.
The steroid hormones we have considered, differ-
ently from polipeptidic hormones, derive from
different metabolic sources, even if both can give
us useful indications about the well-being of the
fetus-placental unity. In fact, we know that E3 is
sinthesized in the placenta from fetal precursors
[21], while E4 is mainly sinthesized in the fetal
liver from placental precursors [13, 22, 29, 31].
Therefore, we can't overlap the theoric value of
these two parameters, but we have studied the
possibility of compare these two assays s clinical
parameters for testing the fetus-placental unity to
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have better informations about the well-being of
the fetus [l, 18, 29]. Moreover, in contrast with
the first announcements about E4 s the most
specific parameter. for monitoring some patho-
logical pregnancies (i.e. isoimmunization Rh,
anencephaly, preeclampsia) [12, 14, 22, 27, 28],
most of the authors now suggest that the E4 assay
can be useful only in few cases (i.e. gestosis) [15,
29]. At last, various authors have very different
opinions about the serial assay of E4 after intra-
venous injection of DHAS [1,8, 30].
Moreover, the only study we know about the RIA
of conjugated E4 does not seem to demonstrate
any advantages of this assay in comparison with
the RIA of unconjugated E4 [9].
On the ground of our studies and our clinical ex-
periences then, for want of a conclusive test, we
think that it's better to assay total E3 instead of
unconjugated E4 for its less biochemical variability
and its easier and faster method of assaying.
J. Perinat. Med. l (1981)
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Summaiy
We have investigated the variability of four honnonal
Parameters used for the endocrine monitoring of the third
trimester of pregnancy (E3, E4, HPL, SPi).
We have observed no circadian rhythm of Estriol, Estetrol,
HPL and SPi- The within-a-day and the day-to-day varia-
tions are much greater for E4 than for E3 and for HPL
thanforSPi.
The Standard deviations were great for the steroids,
especially for E4 and much less for the pro t ein hör-
mones, especially SPi.
This implies that it is necessary to have serial assays of the
steroids to have any confidence in the levels, while good
monitoring could be guaranteed with a smaller number of
assays for HPL and
Keywords: Estetrol, estriol, human placental lactogen, pregnancy-specific-betax-glycoprotein, pregnancy, third tri-
mester.
Zusammenfassung
Schwankungsbreiten bei Hormonbestimmungen während
der endokrinen Überwachung im letzten Schwanger*
schaftstrimester
Uns interessierten die Schwankungsbreiten bei 4 Hormon-
bestimmungen, die als Parameter für die endokrine Über-
wachung während des letzten Schwangerschaftstrimesters
gebräuchlich sind (E4, E3, HPL, SPI).
Bei keinem der 4 Hormone ließ sich einzirkadianer Rhyth-
mus feststellen. Die Schwankungsbreite innerhalb von 24
Stunden wie auch Variationen von Tag zu Tag sind jedoch
bei E4 größer als bei E3 sowie bei HPL größer als bei St^.
Hohe Standardabweichungen fanden wir bei den Steroid-
hormonen, speziell bei E4, während Proteohormonbestim-
mungen, speziell bei E4, während Proteobestimmungen,
und hier besonders SPi-Messungen, geringere Standard-
abweichungen aufwiesen. Das bedeutet, daß für Steroid-
hormonbestimmungen Serienmessungen unbedingt not-
wendig sind, während man bei HPL- und SPi-Bestim-
mungen auch mit weniger Proben eine ausreichende Ge-
nauigkeit erhält.
Schlüsselwörter: HPL, letztes Schwangerschaftstrimester, Östetrol (E4), Östriol (E3), 8 .
Resume
Variations de quelques taux hormonaux dans les liquides
du corps usuellement utilises pour la surveülance endo-
crinienne pendant le troisieme trimestre de grossesse
Nous avons explore la variabilite des quatre parametres
hormonaux utilises dans la surveülance endocrine du
troisieme trimestre de grossesse (E3, E4, HPL, SPj).
Nous avons observe l'absence de rythme circadien pour
Poestradiol. oestetrol, HPL et la SPi- Les variations
au cours d'une joumee et d'une journee a l'autre sont
plus .importantes pour
 4 que pour 3 et pour la HPL
que pour la 8 .
L'ecart-type etait important pour les steroides, speciale-
ment pour la E4, alors qu'il etait faible pour les hormones
proteiques, notamment la SPi.
Ceci signifie qu'il est necessaire de pratiquer des dosages
en serie des steroides afin d'obtenir des valeurs fiables
alors qU'une surveülance de qualite peut etre assuree au
moyen d'un petit nombre de dosages d'HPL et de
Mots-cles: pi-glycoproteine specifique de grossesse, grossesse, hormone placentaire lactogene humaine, oestetrol,
oestriol, troisieme trimestre.
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